The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 13, 2016

Filed:

Jun. 05, 2014
Applicant:

Macau University of Science and Technology, Macau, MO;

Inventors:

Elaine Lai-Han Leung, Mo, MO;

Liang Liu, Mo, MO;

Xing-Xing Fan, Mo, MO;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/68 (2006.01); A61K 31/4741 (2006.01); A61K 33/40 (2006.01); G01N 33/50 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4741 (2013.01); A61K 33/40 (2013.01); C12Q 1/6886 (2013.01); G01N 33/5011 (2013.01); C12Q 2600/136 (2013.01); C12Q 2600/156 (2013.01); G01N 2333/90209 (2013.01); G01N 2333/91205 (2013.01);
Abstract

The present invention relates to methods for novel drug discovery, treatment and selective targeting for Gefitinib-resistant non-small-cell lung cancer (NSCLC) harboring an additional mutation, in particular, to the discovery of a drug candidate or agent identified by the presently claimed method for use in treating and selective targeting Gefitinib-resistant NSCLC harboring T790M mutation.


Find Patent Forward Citations

Leung, Elaine Lai-Han. (2016). Methods for novel drug discovery, treatment and selective targeting for gefitinib-resistant non-small-cell lung cancer harboring t790m mutation (U.S. Patent No. 9439898). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9439898

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…